Antal-Szalmas P - Search Results

1

Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.

Lakatos PL, Kiss LS, Palatka K, Altorjay I, Antal-Szalmas P, Palyu E, Udvardy M, Molnar T, Farkas K, Veres G, Harsfalvi J, Papp J, Papp M. Lakatos PL, et al. Inflamm Bowel Dis. 2011 Mar;17(3):767-77. doi: 10.1002/ibd.21402. Epub 2010 Sep 23. Inflamm Bowel Dis. 2011. PMID: 20865702

2

A novel flow cytometric assay to quantify soluble CD14 concentration in human serum.

Antal-Szalmás P, Szöllosi I, Lakos G, Kiss E, Csípo I, Sümegi A, Sipka S, van Strijp JA, van Kessel KP, Szegedi G. Antal-Szalmás P, et al. Cytometry. 2001 Oct 1;45(2):115-23. doi: 10.1002/1097-0320(20011001)45:2<115::aid-cyto1153>3.0.co;2-m. Cytometry. 2001. PMID: 11590623 Free article.

3

Pgp and FLT3: identification and modulation of two proteins that lead to chemotherapy resistance in acute myeloid leukemia.

Kappelmayer J, Udvardy M, Antal-Szalmás P. Kappelmayer J, et al. Curr Med Chem. 2007;14(5):519-30. doi: 10.2174/092986707780059661. Curr Med Chem. 2007. PMID: 17346144 Review.

4

Detection of internal tandem duplications in the FLT3 gene by different electrophoretic methods.

Bubán T, Koczok K, Földesi R, Szabó G, Sümegi A, Tanyi M, Szerafin L, Udvardy M, Kappelmayer J, Antal-Szalmás P. Bubán T, et al. Clin Chem Lab Med. 2011 Nov 4;50(2):301-10. doi: 10.1515/CCLM.2011.762. Clin Chem Lab Med. 2011. PMID: 22053959

5

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.

Papp M, Vitalis Z, Altorjay I, Tornai I, Udvardy M, Harsfalvi J, Vida A, Kappelmayer J, Lakatos PL, Antal-Szalmas P. Papp M, et al. Liver Int. 2012 Apr;32(4):603-11. doi: 10.1111/j.1478-3231.2011.02689.x. Epub 2011 Dec 6. Liver Int. 2012. PMID: 22145664

6

Laboratory evaluation of a flow cytometric BCR-ABL immunobead assay.

Hevessy Z, Hudák R, Kiss-Sziráki V, Antal-Szalmás P, Udvardy M, Rejtő L, Szerafin L, Kappelmayer J. Hevessy Z, et al. Clin Chem Lab Med. 2011 Dec 17;50(4):689-92. doi: 10.1515/cclm.2011.834. Clin Chem Lab Med. 2011. PMID: 22505532

7

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

Papp M, Sipeki N, Vitalis Z, Tornai T, Altorjay I, Tornai I, Udvardy M, Fechner K, Jacobsen S, Teegen B, Sumegi A, Veres G, Lakatos PL, Kappelmayer J, Antal-Szalmas P. Papp M, et al. J Hepatol. 2013 Sep;59(3):457-66. doi: 10.1016/j.jhep.2013.04.018. Epub 2013 Apr 29. J Hepatol. 2013. PMID: 23639483

8

Immune dysfunction in cirrhosis.

Sipeki N, Antal-Szalmas P, Lakatos PL, Papp M. Sipeki N, et al. World J Gastroenterol. 2014 Mar 14;20(10):2564-77. doi: 10.3748/wjg.v20.i10.2564. World J Gastroenterol. 2014. PMID: 24627592 Free PMC article. Review.

9

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Papp M, et al. J Crohns Colitis. 2015 Aug;9(8):659-68. doi: 10.1093/ecco-jcc/jjv087. Epub 2015 May 12. J Crohns Colitis. 2015. PMID: 25968583 Clinical Trial.

10

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease.

Lakatos PL, Sipeki N, Kovacs G, Palyu E, Norman GL, Shums Z, Golovics PA, Lovasz BD, Antal-Szalmas P, Papp M. Lakatos PL, et al. J Crohns Colitis. 2015 Oct;9(10):891-8. doi: 10.1093/ecco-jcc/jjv127. Epub 2015 Jul 18. J Crohns Colitis. 2015. PMID: 26188353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters